Sectors

Scalable Capital is valued in excess of $460m following a Tengelmann-backed round that lifted the digital wealth manager's total funding to about $130m.

Pfizer and Chiesi-backed genetic drug developer 4DMT has pulled away from a proposed $100m offering after closing series C funding last month.

Existing investor Unilever Ventures returned for the marketing management platform developer's latest round, following its series B a year ago.

Leaps by Bayer has co-led a $28.5m series A round disclosed when precision medicine startup Vesigen Therapeutics publicly launched.

Delta Dental Washington Seed Fund was among the participants in a $10.8m round for the pelvic bone implant developer.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Boehringer Ingelheim Venture Fund followed an investment last September by contributing to a $26.8m round for the Basel spinout.

The grocery e-commerce platform is set to raise the cash in a Tencent-backed series C-plus round, just weeks after it reportedly lined up $300m in series C financing.

The data centre technology provider boosted its overall funding to approximately $335m with a round that included long-term investor Qualcomm Ventures.

The online home insurer is valued at $1.5bn after a series E round backed by Standard Industries, Lennar, Comcast Ventures and Propel Venture Partners.

The CNS disease therapy developer raised a further $20m, adding to a $45m close in April that included GV and Takeda Ventures.